- Home
- FOA vs PYXS Comparison
FOA vs PYXS Comparison
Compare FOA & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOA
- PYXS
- Stock Information
- Founded
- FOA 2013
- PYXS 2018
- Country
- FOA United States
- PYXS United States
- Employees
- FOA N/A
- PYXS N/A
- Industry
- FOA Finance Companies
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- FOA Finance
- PYXS Health Care
- Exchange
- FOA Nasdaq
- PYXS Nasdaq
- Market Cap
- FOA 272.8M
- PYXS 243.5M
- IPO Year
- FOA N/A
- PYXS 2021
- Fundamental
- Price
- FOA $23.64
- PYXS $4.58
- Analyst Decision
- FOA Buy
- PYXS Strong Buy
- Analyst Count
- FOA 2
- PYXS 4
- Target Price
- FOA $27.50
- PYXS $6.67
- AVG Volume (30 Days)
- FOA 91.6K
- PYXS 718.9K
- Earning Date
- FOA 11-04-2025
- PYXS 11-03-2025
- Dividend Yield
- FOA N/A
- PYXS N/A
- EPS Growth
- FOA N/A
- PYXS N/A
- EPS
- FOA N/A
- PYXS N/A
- Revenue
- FOA $318,296,000.00
- PYXS $2,820,000.00
- Revenue This Year
- FOA $21.21
- PYXS N/A
- Revenue Next Year
- FOA $10.95
- PYXS N/A
- P/E Ratio
- FOA N/A
- PYXS N/A
- Revenue Growth
- FOA N/A
- PYXS N/A
- 52 Week Low
- FOA $16.58
- PYXS $0.83
- 52 Week High
- FOA $32.40
- PYXS $4.86
- Technical
- Relative Strength Index (RSI)
- FOA 55.78
- PYXS 65.01
- Support Level
- FOA $22.43
- PYXS $4.23
- Resistance Level
- FOA $23.26
- PYXS $4.86
- Average True Range (ATR)
- FOA 0.81
- PYXS 0.41
- MACD
- FOA 0.14
- PYXS 0.02
- Stochastic Oscillator
- FOA 71.60
- PYXS 81.68
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.